Compare, Analyse Panacea Biotech with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs MYLAN (US) - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   MYLAN
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
MYLAN
Dec-18
PANACEA BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3543,505-   
Low Rs1381,929-   
Sales per share (Unadj.) Rs74.61,612.7-  
Earnings per share (Unadj.) Rs6.743.8-  
Cash flow per share (Unadj.) Rs15.5345.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs57.21,744.7-  
Shares outstanding (eoy) m61.25514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.31.7 195.8%   
Avg P/E ratio x36.862.0 59.3%  
P/CF ratio (eoy) x15.97.9 201.9%  
Price / Book Value ratio x4.31.6 276.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,0611,397,869 1.1%   
No. of employees `0002.335.0 6.6%   
Total wages/salary Rs m1,4710-   
Avg. sales/employee Rs Th1,973.623,706.8 8.3%   
Avg. wages/employee Rs Th635.60-   
Avg. net profit/employee Rs Th176.8643.7 27.5%   
INCOME DATA
Net Sales Rs m4,567829,736 0.6%  
Other income Rs m450-   
Total revenues Rs m4,612829,736 0.6%   
Gross profit Rs m2,030214,705 0.9%  
Depreciation Rs m540155,359 0.3%   
Interest Rs m1,04839,907 2.6%   
Profit before tax Rs m48619,438 2.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77-3,092 -2.5%   
Profit after tax Rs m40922,531 1.8%  
Gross profit margin %44.425.9 171.8%  
Effective tax rate %15.9-15.9 -99.7%   
Net profit margin %9.02.7 329.9%  
BALANCE SHEET DATA
Current assets Rs m2,415463,324 0.5%   
Current liabilities Rs m9,077337,814 2.7%   
Net working cap to sales %-145.915.1 -964.5%  
Current ratio x0.31.4 19.4%  
Inventory Days Days6584 77.9%  
Debtors Days Days7193 76.0%  
Net fixed assets Rs m8,333160,955 5.2%   
Share capital Rs m61442 13.9%   
"Free" reserves Rs m3,4430-   
Net worth Rs m3,504897,623 0.4%   
Long term debt Rs m461968,824 0.0%   
Total assets Rs m13,7552,407,775 0.6%  
Interest coverage x1.51.5 98.4%   
Debt to equity ratio x0.11.1 12.2%  
Sales to assets ratio x0.30.3 96.3%   
Return on assets %10.62.6 408.6%  
Return on equity %11.72.5 465.1%  
Return on capital %38.73.2 1,217.1%  
Exports to sales %20.90-   
Imports to sales %8.10-   
Net fx Rs m7360-   
CASH FLOW
From Operations Rs m1,049172,419 0.6%  
From Investments Rs m-54-89,122 0.1%  
From Financial Activity Rs m-1,011-80,323 1.3%  
Net Cashflow Rs m-201,428 -1.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.63 Rs / USD

Compare PANACEA BIOTECH With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: ELDER PHARMA  ALEMBIC PHARMA  VENUS REMEDIES  CIPLA  SANOFI INDIA  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PANACEA BIOTECH SHARE PRICE


May 7, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS